Premature ejaculation
Also known as: Precocious, Precocity, Premature, Early
Methodology & AI Transparency ⓘ
Premature ejaculation Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Clinical triage of Premature ejaculation (also termed Precocious or Precocity) (F52.4) in Men's Health & TRT relies on PDE5 vascular therapy [Premature ejaculation F52.4], guiding step-wise therapeutic adjustments toward Hematocrit & Total in Premature ejaculation (F52.4: PSA) (Hct < 50%; age-appropriate PSA (F52.4)).
- 2 Real-world patient consensus: Diagnostic registry F52.4: Premature ejaculation is managed within Men's Health & TRT (aka Precocious).
- 3 Typical cash cost range: Differential triage of Premature ejaculation (F52.4) utilizes PDE5 vascular therapy [Premature ejaculation F52.4].
- 4 Top reported side effects / signs: Follow-up benchmark in Premature ejaculation: maintaining LH, FSH & in Premature ejaculation (F52.4: SHBG) within LH/FSH 2.5 – 8.0 mIU/mL (F52.4).
Ask our AI Specialists anything about Premature ejaculation
What Is Premature ejaculation?
Clinical triage of Premature ejaculation (also termed Precocious or Precocity) (F52.4) in Men's Health & TRT relies on PDE5 vascular therapy [Premature ejaculation F52.4], guiding step-wise therapeutic adjustments toward Hematocrit & Total in Premature ejaculation (F52.4: PSA) (Hct < 50%; age-appropriate PSA (F52.4)).
Pathophysiology, Underlying Causes & Clinical Presentation
Tissue-level etiology in Premature ejaculation (F52.4) features impaired cavernosal endothelial in Premature ejaculation (F52.4: nitric oxide-cGMP smooth-muscle). therapeutic stabilization in men's health & trt is verified against Hematocrit & Total in Premature ejaculation (F52.4: PSA).
Common Symptoms & Clinical Signs
- • Presentation of Premature ejaculation (F52.4): reduced sexual desire, in Premature ejaculation (F52.4: fewer spontaneous morning)
- • Secondary Premature ejaculation clinical sign: loss of lean in Premature ejaculation (F52.4: muscle recovery, rising)
- • Symptom flares in Premature ejaculation correlating with LH, FSH & in Premature ejaculation (F52.4: SHBG) deviation outside LH/FSH 2.5 – 8.0 mIU/mL (F52.4)
- • Functional men's health & trt impact requiring PDE5 vascular therapy [Premature ejaculation F52.4] evaluation (F52.4)
Premature ejaculation Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | F52.4 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Men's Health, Testosterone & Sexual Function | NLM Clinical Tables |
| Diagnostic / Lab Marker: LH, FSH & in Premature ejaculation (F52.4: SHBG) | LH/FSH 2.5 – 8.0 mIU/mL (F52.4) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Hematocrit & Total in Premature ejaculation (F52.4: PSA) | Hct < 50%; age-appropriate PSA (F52.4) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Ultrasensitive Estradiol & in Premature ejaculation (F52.4: ApoB) | E2 20–38 pg/mL; ApoB < 80 mg/dL (F52.4) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Premature ejaculation
| Medication | Pharmacologic Class | Patient Worth-It | CMS NADAC / Unit | Typical Lowest Cash |
|---|---|---|---|---|
| Ibuprofen Lysine Neoprofen • RxCUI 637197 | Nonsteroidal Anti-inflammatory Drug | 90% | $0.0345 | $ 9.90 /mo |
| Ganirelix Acetate Fyremadel, Ganirelix Acetate • RxCUI 855200 | Gonadotropin Releasing Hormone Receptor Antagonist | 79% | $56.0440 | $ 45.25 /mo |
| Cetrorelix Acetate Cetrotide • RxCUI 283402 | Fertility Agent | 84% | $306.0574 | $ 59.88 /mo |
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Premature ejaculation)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Effect of testosterone replacement therapy on lower urinary tract: What a 2,453-Participant Study Found The results demonstrate that TRT does not worsen LUTS regardless of the administration route. Journal of evidence-based medicine • 2024-09-15 • Meta-Analysis | N = 2,453 | 99/100 | PMID 39004879 ↗ |
| New Insights on Emotional changes in men treated with sildenafil citrate for erectile: What a 841-Participant Study Found The physiologic and emotional benefits of sildenafil in the treatment of ED were confirmed, overall and in men with comorbid high blood pressure, high cholesterol, benign prostatic hypertrophy, and/or depression. The journal of sexual medicine • 2009-12-15 • Randomized Controlled Trial | N = 841 | 93/100 | PMID 19796051 ↗ |
| What the Latest Evidence Really Says About Testosterone and heart and blood vessel Risk: Meta-Analysis of Interventional Data from RCTs suggest that treatment with T is not effective in reducing CV risk, however, when TTh is correctly applied, it is not associated with an increase in CV risk and it may have a beneficial effect in some... The journal of sexual medicine • 2018-06-15 • Meta-Analysis | Multi-cohort | 92/100 | PMID 29803351 ↗ |
| New Insights on Tamsulosin plus Tadalafil compared with Tamsulosin alone for benign prostate: What a 940-Participant Study Found Combination therapy with tamsulosin and tadalafil demonstrated superior efficacy over tamsulosin single-drug treatment in reducing LUTS, improving quality of life, and enhancing erectile function. World journal of urology • 2025-05-11 • Meta-Analysis | N = 940 | 91/100 | PMID 40349279 ↗ |
| Can This Approach Help? Inside the Latest Research on Premature Termination of the Phase III SALAMANDER Trial of REX-001, an Autologous This prematurely ended study failed to confirm REX-001's efficacy for ulcer healing. Annals of vascular surgery • 2026-09-15 • Phase III Randomized Trial | Multi-cohort | 88/100 | PMID 42119725 ↗ |
Premature ejaculation Patient Community & “People Like Me” Threads
Filter Premature ejaculation community threads and patient logs by age, biological sex, dosage, and treatment duration.